Usòrò:PegUricase.png
Otu nyochaa a ha:615 × 599 piksels Ndị ọzọ mkpebi:246 × 240 piksels | 493 × 480 piksels | 788 × 768 piksels | 1,051 × 1,024 piksels | 2,192 × 2,136 piksels.
Failụ si na nke mbu (2,192 × 2,136 pixel, ívù akwukwo orunótu: 1.65 MB, MIME nke: image/png)
Mmẹkụwátá
| Nkówá |
English: A comparison of uricase (pdb:1uox) and PEG-uricase (model). PEG-uricase includes 40 polymers of 10kDa PEG. PEGylation improves its solubility at physiological pH, increases serum half-life and reduces immunogenicity without compromising activity. Upper images show the whole tetramer, lower images show an example of one of the lysines that is PEGylated. (PEG-uricase model from reference[1], only 36 PEG polymers included) |
| Ǹgụ́ụ̀bọ̀chị̀ | |
| Mkpọlọ́gwụ̀ | Orü ọnwé |
| Odé ákwụ́kwọ́ | Evolution and evolvability |
Nkwényé
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the Creative Commons Attribution 4.0 International license.
- I wepulara nóru:
- i nye – ikọpị,ikekasi na izịpụ ọru a
- i dowaria – igbanwee ọrụ a
- Ọ ga bụ na ọnọdụ ndi a:
- í-kpó-áhà – Ị ga-enyerịrị ugo kwesịrị ekwesị, nye njikọ na ikikere ahụ, ma gosikwa ma emere mgbanwe. Ị nwere ike ime ya n'ụzọ ezi uche ọ bụla, mana ọ bụghị n'ụzọ ọ bụla na-egosi na onye nyere ikikere kwadoro gị maọbụ ojiji gị.
- ↑ (3 January 2008). "PEG-uricase in the management of treatment-resistant gout and hyperuricemia.". Advanced drug delivery reviews 60 (1): 59-68. PMID 17826865.
Ịta nke usòrò
Bìri èhì/ogè k'ị hụ òtù ụ̀fa dị̀ m̀gbè ahụ̀.
| Èhì/Ogè | Mbọ-aka | Ógólógó na asaá | Òjìème | Nkwute | |
|---|---|---|---|---|---|
| dị ùgbu â | 23:50, 21 Febụwarị 2015 | | 2,192 × 2,136 (1.65 MB) | Evolution and evolvability | User created page with UploadWizard |
Ojiji faịlụ
Ọdighi ihuakwụkwọ nwere failụ a.
Ejiji failụ zụrụ ọha
Wikis ndi a edeputara na eji kwa failụ a:
- Ihe eji na cs.wikipedia.org
- Ihe eji na de.wikipedia.org
- Ihe eji na en.wikipedia.org
- Ihe eji na gl.wikipedia.org
- Ihe eji na ms.wikipedia.org
